<DOC>
	<DOC>NCT00141388</DOC>
	<brief_summary>To evaluate the long-term safety and efficacy of pregabalin in patients with partial seizures.</brief_summary>
	<brief_title>To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Epilepsies, Partial</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Must have met the inclusion criteria for the preceding doubleblind study Have received doubleblind study medication and wish to receive openlabel pregabalin. Cannot have absence seizures.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2009</verification_date>
</DOC>